Physician profile
Amy Broyles Young
NPI 1386602779
$1,072.35
in general payments reported to CMS, 2019-2025
16 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $39.25 · 2021: $138 · 2022: $58.41 · 2023: $300 · 2024: $130 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $210.77 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $145.08 | 2019-2023 | |
| Allergan, INC. | $136.42 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $100.14 | 2024-2025 | Xdemvy |
| Genentech USA, INC. | $82.07 | 2023-2025 | Vabysmo |
| Aerie Pharmaceuticals, INC. | $64.25 | 2019-2021 | |
| Alcon Vision LLC | $55.38 | 2021-2025 | Hydrus Microstent |
| Carl Zeiss Meditec USA, INC. | $53.03 | 2024-2025 | Cirrus Hd-Oct |
| Carl Zeiss Meditec, INC. | $41.55 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $39.92 | 2019-2021 | |
| Abbvie INC. | $37.90 | 2022-2023 | Lumigan, Alphagan P |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.66 | 2019 | |
| Sun Pharmaceutical Industries INC. | $20.38 | 2023 | Cequa |
| Derma Sciences, INC. | $20.01 | 2019 | |
| Shire North American Group INC | $16.23 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13.56 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.